RGEN

Repligen (RGEN)

About Repligen (RGEN)

Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. It operates through the North America. Europe, and Asia Pacific Region or Other geographical segments. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.

Details

Daily high

$160.99

Daily low

$156.01

Price at open

$160.00

52 Week High

$182.52

52 Week Low

$102.96

Market cap

9.0B

Dividend yield

0.00%

Volume

671,006

Avg. volume

678,300

P/E ratio

6,248.25

Repligen News